帕妥珠单抗、曲妥珠单抗和多西他赛联合治疗与转移性乳腺癌患者总生存的关系。
Association of Pertuzumab, Trastuzumab, and Docetaxel Combination Therapy With Overall Survival in Patients With Metastatic Breast Cancer.
机构信息
Global Access, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Pharma International Informatics, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
出版信息
JAMA Netw Open. 2021 Jan 4;4(1):e2027764. doi: 10.1001/jamanetworkopen.2020.27764.
Abstract
This cohort study compares the findings of combined pertuzumab, trastuzumab, and docetaxel therapy in women with metastatic breast cancer with those in the CLEOPATRA trial.
摘要
这项队列研究比较了曲妥珠单抗、帕妥珠单抗和多西他赛联合治疗转移性乳腺癌女性患者的结果与 CLEOPATRA 试验的结果。
Zotero 插件